What is the address of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX?

The registered office of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is located at Rue de Plainevaux 185, 4100 Seraing.

Is DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX still active?

Yes. According to the CBE (30 October 2026) DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is active, legal situation “Normale toestand”, started on 28 December 2001.

Is DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX registered on Peppol?

No, DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is currently not registered on the Peppol network.

What is the enterprise number of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX?

The enterprise number of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is BE0476509728.

When was DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX founded?

DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX was founded on 28 December 2001.

Who are the directors of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX?

According to the 2025 annual accounts, the directors of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX are: Bernard MANS.

Is DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX make in 2025?

DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX posted a profit after taxes of € 66,275 in financial year 2025.

What is the revenue of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX?

As a small company, DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 114,383.

DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX (Private Limited)

Dossier DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX, printed on 30 October 2026 from databakkes.be/en/0476509728/docteur-mans-maladies-et-chirurgie-des-yeux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2022.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX from Seraing, company number BE0476509728, closed financial year 2025 with a result of € 66,275 after tax. For that financial year DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX recorded a gross margin of € 114,383 and equity of € 309,698. Compared with financial year 2024, the result moved from € -8,189 to € 66,275. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Growing

€ 309,698

▲ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 66,275

▲ still € 8,189 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 385,540

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 38,089 paid out

57 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 21,657

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 11,869

▼ 18% vs 2024

€ 7,632 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,273

▼ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,802

▲ 65% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 135,182 Gross margin 2022: € 135,182 First fiscal year in the series	€ 118,836 Gross margin 2023: € 118,836 ▼ 12% vs 2022 (€ 135,182) Unfavourable step	€ 74,066 Gross margin 2024: € 74,066 ▼ 38% vs 2023 (€ 118,836) Unfavourable step	€ 114,383 Gross margin 2025: € 114,383 ▲ 54% vs 2024 (€ 74,066) Favourable step	▲ 54%
Profit after taxes	€ 50,652 Profit after taxes 2022: € 50,652 First fiscal year in the series	€ 44,569 Profit after taxes 2023: € 44,569 ▼ 12% vs 2022 (€ 50,652) Unfavourable step	€ -8,189 Profit after taxes 2024: € -8,189 ▼ € 52,758 vs 2023 (€ 44,569) Unfavourable step	€ 66,275 Profit after taxes 2025: € 66,275 ▲ € 74,464 vs 2024 (€ -8,189) Favourable step	▲ € 74,464
Equity	€ 342,035 Equity 2022: € 342,035 First fiscal year in the series	€ 361,605 Equity 2023: € 361,605 ▲ 6% vs 2022 (€ 342,035) Favourable step	€ 281,512 Equity 2024: € 281,512 ▼ 22% vs 2023 (€ 361,605) Unfavourable step	€ 309,698 Equity 2025: € 309,698 ▲ 10% vs 2024 (€ 281,512) Favourable step	▲ 10%
Total debts	€ 119,140 Total debts 2022: € 119,140 First fiscal year in the series	€ 78,629 Total debts 2023: € 78,629 ▼ 34% vs 2022 (€ 119,140) Favourable step	€ 122,164 Total debts 2024: € 122,164 ▲ 55% vs 2023 (€ 78,629) Unfavourable step	€ 129,897 Total debts 2025: € 129,897 ▲ 6% vs 2024 (€ 122,164) Unfavourable step	▲ 6%
Cash	€ 394,040 Cash 2022: € 394,040 First fiscal year in the series	€ 378,896 Cash 2023: € 378,896 ▼ 4% vs 2022 (€ 394,040) Unfavourable step	€ 326,774 Cash 2024: € 326,774 ▼ 14% vs 2023 (€ 378,896) Unfavourable step	€ 385,540 Cash 2025: € 385,540 ▲ 18% vs 2024 (€ 326,774) Favourable step	▲ 18%
Retained profit	€ 335,835 Retained profit 2022: € 335,835 First fiscal year in the series	€ 355,405 Retained profit 2023: € 355,405 ▲ 6% vs 2022 (€ 335,835) Favourable step	€ 275,312 Retained profit 2024: € 275,312 ▼ 23% vs 2023 (€ 355,405) Unfavourable step	€ 303,498 Retained profit 2025: € 303,498 ▲ 10% vs 2024 (€ 275,312) Favourable step	▲ 10%
Dividend	€ 44,000 Dividend 2022: € 44,000 First fiscal year in the series	€ 25,000 Dividend 2023: € 25,000 ▼ 43% vs 2022 (€ 44,000) Unchanged	€ 71,904 Dividend 2024: € 71,904 ▲ 188% vs 2023 (€ 25,000) Unchanged	€ 38,089 Dividend 2025: € 38,089 ▼ 47% vs 2024 (€ 71,904) Unchanged	▼ 47%
Bank debt	€ 27,582 Bank debt 2022: € 27,582 First fiscal year in the series	€ 21,073 Bank debt 2023: € 21,073 ▼ 24% vs 2022 (€ 27,582) Favourable step	€ 14,495 Bank debt 2024: € 14,495 ▼ 31% vs 2023 (€ 21,073) Favourable step	€ 11,869 Bank debt 2025: € 11,869 ▼ 18% vs 2024 (€ 14,495) Favourable step	▼ 18%
Balance sheet total	€ 461,175 Balance sheet total 2022: € 461,175 First fiscal year in the series	€ 440,233 Balance sheet total 2023: € 440,233 ▼ 5% vs 2022 (€ 461,175) Unchanged	€ 403,676 Balance sheet total 2024: € 403,676 ▼ 8% vs 2023 (€ 440,233) Unchanged	€ 439,594 Balance sheet total 2025: € 439,594 ▲ 9% vs 2024 (€ 403,676) Unchanged	▲ 9%

Key figures of DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX?

What happened at DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 66,275. Source: NBB ↗
Dec 28, 2001 Start of the company according to the CBE. KBO
Dec 26, 2001 New establishment in Seraing. KBO

In short

From € 50,652 profit in 2022 to € 66,275 profit in 2025.

Paid € 71,765 in corporate taxes since 2022.

Best year ever: 2025, with € 66,275 profit.

Paid out € 178,993 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bernard MANS

DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX

Behind DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is Bernard MANS.

Directors

According to the 2025 annual accounts

Bernard MANS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Plainevaux 185

4100 Seraing

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

BURGEST

€ 126,304 gross margin · 2025

COUVEUSES DUCATILLON

Association des copropriétaires de la Résidence les Yvelines sise rue de Plainevaux n°185 à Seraing

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.509.728
VAT number: BE 0476.509.728
Registered office: Rue de Plainevaux 185, 4100 Seraing
Names & denominations: DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 December 2001
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗